MedTrace Logo

Determinants on Rocuronium Dose for Deep Block in Bariatric Surgery

NCT04709406 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-01-14

No results posted yet for this study

Summary

Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromuscular blockade in bariatric surgery.

Conditions

  • Bariatric Surgery

Interventions

DRUG

deep neuromuscular blockade in bariatric surgery

obese patients who underwent bariatric surgery

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-10-31
Completion
2021-10-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04709406 on ClinicalTrials.gov